Trial intelligence / Profile preview

Rivastigmine versus placebo fMRI crossover study in Parkinson's disease with visual hallucinations

NL-OMON33228Active, not recruiting

Sponsor
Neurologie
Start
Jun 2009
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Randomised, single-blind trial of rivastigmine in Parkinson's disease (PD) (2 arms), sponsored by Neurologie. Started Jun 2009; status: active, not recruiting.

02

Drugs

rivastigmine
03

Conditions

Parkinson's disease (PD)

Beyond the preview

Go deeper on NL-OMON33228.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON33228.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call